These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11237223)

  • 1. Leptin controls bone formation through a hypothalamic relay.
    Karsenty G
    Recent Prog Horm Res; 2001; 56():401-15. PubMed ID: 11237223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.
    Ducy P; Amling M; Takeda S; Priemel M; Schilling AF; Beil FT; Shen J; Vinson C; Rueger JM; Karsenty G
    Cell; 2000 Jan; 100(2):197-207. PubMed ID: 10660043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central control of bone formation.
    Takeda S; Karsenty G
    J Bone Miner Metab; 2001; 19(3):195-8. PubMed ID: 11368306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leptin: factor in the central nervous system regulation of bone mass. Development of a new understanding of bone remodeling, skeletal reconstruction, skeletal preservation and skeletal repair].
    Amling M; Schilling AF; Haberland M; Rueger JM
    Orthopade; 2001 Jul; 30(7):418-24. PubMed ID: 11515179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence between bone and energy homeostases: leptin regulation of bone mass.
    Karsenty G
    Cell Metab; 2006 Nov; 4(5):341-8. PubMed ID: 17084709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of transthyretin in leptin-deficient ob/ob mice is not causative for their major phenotypic abnormalities.
    Rendenbach C; Ganswindt S; Seitz S; Barvencik F; Huebner AK; Baranowsky A; Streichert T; Niemeier A; Heeren J; Amling M; Bartelt A; Schinke T
    J Neuroendocrinol; 2013 Jan; 25(1):14-22. PubMed ID: 22849972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and bone: does the brain control bone biology?
    Fleet JC
    Nutr Rev; 2000 Jul; 58(7):209-11. PubMed ID: 10941257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.
    Allison SJ; Baldock PA; Enriquez RF; Lin E; During M; Gardiner EM; Eisman JA; Sainsbury A; Herzog H
    J Bone Miner Res; 2009 Feb; 24(2):294-304. PubMed ID: 18847327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain.
    Itateyama E; Chiba S; Sakata T; Yoshimatsu H
    Exp Biol Med (Maywood); 2003 Nov; 228(10):1132-7. PubMed ID: 14610251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.
    Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM
    Circulation; 2003 Aug; 108(6):754-9. PubMed ID: 12885755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of obesity on bone metabolism].
    Takeda S
    Clin Calcium; 2008 May; 18(5):632-7. PubMed ID: 18445881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.
    Baldock PA; Allison S; McDonald MM; Sainsbury A; Enriquez RF; Little DG; Eisman JA; Gardiner EM; Herzog H
    J Bone Miner Res; 2006 Oct; 21(10):1600-7. PubMed ID: 16995815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone mass regulation by leptin: a hypothalamic control of bone formation].
    Elefteriou F; Karsenty G
    Pathol Biol (Paris); 2004 Apr; 52(3):148-53. PubMed ID: 15063934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment.
    Crépin D; Benomar Y; Riffault L; Amine H; Gertler A; Taouis M
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):1-11. PubMed ID: 24394757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models.
    Ahmad A; Ali T; Kim MW; Khan A; Jo MH; Rehman SU; Khan MS; Abid NB; Khan M; Ullah R; Jo MG; Kim MO
    Metabolism; 2019 Jan; 90():31-43. PubMed ID: 30473057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal phenotype of the leptin receptor-deficient db/db mouse.
    Williams GA; Callon KE; Watson M; Costa JL; Ding Y; Dickinson M; Wang Y; Naot D; Reid IR; Cornish J
    J Bone Miner Res; 2011 Aug; 26(8):1698-709. PubMed ID: 21328476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair.
    Pogoda P; Priemel M; Rueger JM; Amling M
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S18-24. PubMed ID: 15551056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
    Makimura H; Mizuno TM; Roberts J; Silverstein J; Beasley J; Mobbs CV
    Diabetes; 2000 Nov; 49(11):1917-23. PubMed ID: 11078460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels.
    Kveiborg M; Chiusaroli R; Sims NA; Wu M; Sabatakos G; Horne WC; Baron R
    Endocrinology; 2002 Nov; 143(11):4304-9. PubMed ID: 12399426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.